Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

51 projects found matching your search criteria :

  1. Flavonoid phytoprogestins as novel non-steroidal progesterone receptor modulators in a nutraceutical approach to endomet...

    Call: PRELUDIUM 24 , Panel: NZ9

    Principal investigator: Agata Gołąbek-Grenda

    Uniwersytet Przyrodniczy w Poznaniu

  2. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Beata Kaleta

    Warszawski Uniwersytet Medyczny

  3. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

  4. Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

  5. Adopted orphan nuclear receptors as new regulators of testis immune privilege

    Call: SONATA 20 , Panel: NZ3

    Principal investigator: dr Alicja Kinga Kamińska

    Uniwersytet Jagielloński

  6. Novel receptor materials for the construction of a bioelectronic nose for the rapid and efficient detection of lung canc...

    Call: OPUS 25 , Panel: ST5

    Principal investigator: prof. Wojciech Kamysz

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  7. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

    Call: SONATA 18 , Panel: NZ3

    Principal investigator: dr hab. Aleksandra Rutkowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  8. Studies on the post-receptor mechanisms of TSPO in search of a novel therapeutic target of metabolic syndrome

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: dr Łukasz Kurach

    Uniwersytet Medyczny w Lublinie

  9. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

  10. Soluble scavenger receptor cysteine-rich domain-containing protein - SSc5D, a new player of innate immunity in turkey (M...

    Call: OPUS 23 , Panel: NZ9

    Principal investigator: dr hab. Mariola Słowińska

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  11. Novel tricyclic glycomimetics as DC-SIGN receptor ligands.

    Call: OPUS 22 , Panel: ST4

    Principal investigator: dr Mykhaylo Potopnyk

    Instytut Chemii Organicznej Polska Akademia Nauk

  12. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  13. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński, Collegium Medicum

  14. New approach to the treatment of Alzheimer's disease targetingresolution of inflammation and modulation of biomechanical...

    Call: OPUS 22 , Panel: NZ4

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

  15. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

  16. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Anna Piotrowska-Murzyn

    Instytut Farmakologii PAN

  17. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

  18. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

  19. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  20. New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of gliobl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: dr Przemysław Patryk Zaręba

    Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

  21. New mechanisms regulating acetylcholine receptors at the neuromuscular junction

    Call: OPUS 19 , Panel: NZ3

    Principal investigator: dr hab. Tomasz Jacek Prószyński

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

  22. Recognition of expression and function of new neuropeptide - phoenixin-14 in porcine corpus luteum.

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Ewa Maria Mlyczyńska

    Uniwersytet Jagielloński, Wydział Biologii

  23. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

    Call: SONATINA 4 , Panel: NZ7

    Principal investigator: Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

  24. Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur...

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: Marcin Józef Drop

    Uniwersytet Jagielloński, Collegium Medicum

  25. Effects of a novel nonaddictive opioid on response to stress

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: dr Łucja Elżbieta Szumiec

    Instytut Farmakologii PAN

  26. New calcitriol analogues with unnatural D ring

    Call: PRELUDIUM 16 , Panel: ST5

    Principal investigator: Adrian Fabisiak

    Uniwersytet Warszawski, Wydział Chemii

  27. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni...

    Call: SONATA 14 , Panel: NZ7

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  28. Characterization of genetic determinants of the mannose-specific phosphotransferase system (Man-PTS) determining sensiti...

    Call: PRELUDIUM 15 , Panel: NZ1

    Principal investigator: dr Aleksandra Tymoszewska

    Instytut Biochemii i Biofizyki PAN

  29. New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 ...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: dr Klaudia Kwiatkowski

    Instytut Farmakologii PAN

  30. New derivatives of clopidogrel - enantioselective biosynthesis and antiplatelet activity in vitro

    Call: PRELUDIUM 14 , Panel: NZ7

    Principal investigator: Adam Edward Sikora

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

  31. Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  32. STIM proteins as new regulators of NMDA receptor trafficking in neurons

    Call: SONATA BIS 7 , Panel: NZ3

    Principal investigator: dr Joanna Edyta Gruszczyńska-Biegała

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  33. New receptors for C-reactive protein recognition - generation, characterization and application towards fast differentia...

    Call: SONATA 13 , Panel: ST5

    Principal investigator: dr Katarzyna Szot-Karpińska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  34. Novel ligands of histamine receptor H4 as potential anti-allergic and anti-inflammatory drugs

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

  35. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

    Call: OPUS 12 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  36. Evaluation of relationship between markers of Epstein-Barr virus infection and selected immune parameters in patients wi...

    Call: OPUS 12 , Panel: NZ6

    Principal investigator: prof. Wojciech Tomasz Załuska

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

  37. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Michał Karol Załuski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  38. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha...

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  39. Maternal diet during gestation and nutrition as a risk factor for cocaine use disorder in offspring - preclinical behavi...

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii PAN

  40. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

  41. New selective antagonists of ionotropic glutamate non-NMDA receptors

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: dr Ewa Monika Szymańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  42. The new homology model of H3 histaminic receptor - structure, interaction with ligand

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: Jakub Józef Jończyk

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  43. Novel polyelectrolytes as potential inhibitors of HSV-1 virus - synthesis, properties and mechanism of action

    Call: OPUS 7 , Panel: ST5

    Principal investigator: prof. Maria Nowakowska

    Uniwersytet Jagielloński, Wydział Chemii

  44. Stearoyl-CoA desaturase and intracellular lipid signaling as novel players in regulation of thyroid hormone action in th...

    Call: OPUS 7 , Panel: NZ4

    Principal investigator: dr hab. Paweł Dobrzyń

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  45. Novel type modulators of purinergic receptors - Synthesis and study of receptor-ligand interaction

    Call: OPUS 7 , Panel: NZ1

    Principal investigator: prof. Zbigniew Jan Leśnikowski

    Instytut Biologii Medycznej PAN

  46. Analysis of the structural and functional mechanisms of action of the nicotinic receptors modulators.

    Call: SONATA 5 , Panel: NZ7

    Principal investigator: dr Katarzyna Małgorzata Targowska-Duda

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

  47. Novel C3 symmetric triptycene derivatives useful for construction of artificial anion receptors

    Call: PRELUDIUM 4 , Panel: ST5

    Principal investigator: dr Jarosław Marek Granda

    Instytut Chemii Organicznej Polska Akademia Nauk

  48. PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGIC...

    Call: SONATA BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

  49. Novel approach to the chiral recognition of organic cations and anions - dynamic combinatorial chemistry

    Call: MAESTRO 1 , Panel: ST5

    Principal investigator: prof. Janusz Jurczak

    Instytut Chemii Organicznej Polska Akademia Nauk

  50. Binding isotope effects as new, unique tool for studies of receptor - ligand interactions

    Call: MAESTRO 1 , Panel: ST4

    Principal investigator: prof. Piotr Paneth

    Politechnika Łódzka

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy